# GeneDx Holdings Corp.: filings

WGS · Nasdaq · CIK 1818331 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wgs.md) · [Financials](/companies/wgs/financials.md) · [Filings](/companies/wgs/filings.md) · [Insiders](/companies/wgs/insiders.md)

## Reports and events: 126 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 377, 8-K 65, 144 56, 3 33, 424B3 26, 10-Q 18, DEFA14A 18, SC 13D/A 15, 4/A 14, CORRESP 12, UPLOAD 12, S-8 10, SC 13G 8, EFFECT 7, SC 13G/A 7, SCHEDULE 13D/A 7, 10-K 6, 424B5 5, DEF 14A 5, ARS 4, SCHEDULE 13G/A 4, S-1 3, S-8 POS 3, SC 13D 3, SCHEDULE 13G 3, 25-NSE 2, 425 2, DEFM14A 2, POS AM 2, PREM14A 2, PRER14A 2, S-1/A 2, S-3 2, 10-K/A 1, 424B4 1, 5 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, NT 10-Q 1, POS EX 1, PRE 14A 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-03 | 16:19 ET | [10-Q](/filings/0001628280-26-051878.md) | Quarterly report, period 2026-06-30 | 0001628280-26-051878 |
| 2026-08-03 | 16:14 ET | [8-K](/filings/0001628280-26-051852.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-051852 |
| 2026-06-23 | 08:35 ET | [8-K](/filings/0001628280-26-044806.md) | 5.07 Shareholder vote results | 0001628280-26-044806 |
| 2026-06-16 | 08:39 ET | [8-K](/filings/0001628280-26-043431.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-043431 |
| 2026-05-22 | 17:20 ET | [SCHEDULE 13D/A](/filings/0000919574-26-003685.md) | Ownership report, active investor, amended | 0000919574-26-003685 |
| 2026-05-15 | 19:05 ET | [SCHEDULE 13D/A](/filings/0001011438-26-000350.md) | Ownership report, active investor, amended | 0001011438-26-000350 |
| 2026-05-11 | 21:20 ET | [SCHEDULE 13D/A](/filings/0001011438-26-000275.md) | Ownership report, active investor, amended | 0001011438-26-000275 |
| 2026-05-04 | 16:15 ET | [10-Q](/filings/0001818331-26-000041.md) | Quarterly report, period 2026-03-31 | 0001818331-26-000041 |
| 2026-05-04 | 16:09 ET | [8-K](/filings/0001818331-26-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-26-000039 |
| 2026-04-30 | 16:09 ET | [DEF 14A](/filings/0001818331-26-000030.md) | Proxy statement, period 2025-12-31 | 0001818331-26-000030 |
| 2026-03-02 | 07:02 ET | [8-K](/filings/0001818331-26-000021.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001818331-26-000021 |
| 2026-02-23 | 08:21 ET | [10-K](/filings/0001818331-26-000015.md) | Annual report, period 2025-12-31 | 0001818331-26-000015 |
| 2026-02-23 | 08:16 ET | [8-K](/filings/0001818331-26-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-26-000014 |
| 2026-01-12 | 17:10 ET | [8-K](/filings/0001818331-26-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818331-26-000005 |
| 2025-10-28 | 06:52 ET | [10-Q](/filings/0001818331-25-000130.md) | Quarterly report, period 2025-09-30 | 0001818331-25-000130 |
| 2025-10-28 | 06:43 ET | [8-K](/filings/0001818331-25-000128.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-25-000128 |
| 2025-09-18 | 08:16 ET | [8-K](/filings/0001818331-25-000121.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001818331-25-000121 |
| 2025-08-26 | 11:27 ET | [SCHEDULE 13D/A](/filings/0000919574-25-005136.md) | Ownership report, active investor, amended | 0000919574-25-005136 |
| 2025-07-29 | 08:18 ET | [10-Q](/filings/0001818331-25-000108.md) | Quarterly report, period 2025-06-30 | 0001818331-25-000108 |
| 2025-07-29 | 07:21 ET | [8-K](/filings/0001818331-25-000105.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-25-000105 |
| 2025-06-18 | 16:11 ET | [8-K](/filings/0001818331-25-000086.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001818331-25-000086 |
| 2025-05-07 | 16:01 ET | [SCHEDULE 13D/A](/filings/0001315863-25-000377.md) | Ownership report, active investor, amended | 0001315863-25-000377 |
| 2025-04-30 | 16:33 ET | [DEF 14A](/filings/0001818331-25-000075.md) | Proxy statement, period 2024-12-31 | 0001818331-25-000075 |
| 2025-04-30 | 07:04 ET | [10-Q](/filings/0001818331-25-000071.md) | Quarterly report, period 2025-03-31 | 0001818331-25-000071 |
| 2025-04-30 | 07:02 ET | [8-K](/filings/0001818331-25-000070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-25-000070 |
| 2025-04-16 | 07:01 ET | [8-K](/filings/0001818331-25-000057.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818331-25-000057 |
| 2025-02-21 | 16:30 ET | [SCHEDULE 13D/A](/filings/0000950170-25-024904.md) | Ownership report, active investor, amended | 0000950170-25-024904 |
| 2025-02-20 | 07:59 ET | [10-K](/filings/0001818331-25-000021.md) | Annual report, period 2024-12-31 | 0001818331-25-000021 |
| 2025-02-18 | 20:01 ET | [SCHEDULE 13D/A](/filings/0000950170-25-022688.md) | Ownership report, active investor, amended | 0000950170-25-022688 |
| 2025-02-18 | 06:50 ET | [8-K](/filings/0001818331-25-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-25-000013 |
| 2025-01-13 | 08:36 ET | [8-K](/filings/0001818331-25-000004.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818331-25-000004 |
| 2025-01-02 | 17:14 ET | [8-K](/filings/0001818331-25-000002.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818331-25-000002 |
| 2024-11-19 | 20:00 ET | [SC 13D/A](/filings/0001341004-24-000216.md) | Ownership report, active investor, amended | 0001341004-24-000216 |
| 2024-11-04 | 17:00 ET | [SC 13D/A](/filings/0001341004-24-000180.md) | Ownership report, active investor, amended | 0001341004-24-000180 |
| 2024-10-29 | 08:18 ET | [10-Q](/filings/0001818331-24-000059.md) | Quarterly report, period 2024-09-30 | 0001818331-24-000059 |
| 2024-10-29 | 08:10 ET | [8-K](/filings/0001818331-24-000057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-24-000057 |
| 2024-07-30 | 16:19 ET | [10-Q](/filings/0001818331-24-000042.md) | Quarterly report, period 2024-06-30 | 0001818331-24-000042 |
| 2024-07-30 | 16:12 ET | [8-K](/filings/0001818331-24-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-24-000041 |
| 2024-06-24 | 16:36 ET | [8-K](/filings/0001818331-24-000036.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001818331-24-000036 |
| 2024-05-31 | 16:55 ET | [SC 13D/A](/filings/0000919574-24-003430.md) | Ownership report, active investor, amended | 0000919574-24-003430 |
| 2024-04-29 | 17:10 ET | [8-K](/filings/0001818331-24-000031.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001818331-24-000031 |
| 2024-04-29 | 16:19 ET | [DEF 14A](/filings/0001818331-24-000025.md) | Proxy statement, period 2023-12-31 | 0001818331-24-000025 |
| 2024-04-29 | 16:13 ET | [10-Q](/filings/0001818331-24-000023.md) | Quarterly report, period 2024-03-31 | 0001818331-24-000023 |
| 2024-04-29 | 16:09 ET | [8-K](/filings/0001818331-24-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-24-000021 |
| 2024-02-23 | 16:56 ET | [10-K](/filings/0001818331-24-000008.md) | Annual report, period 2023-12-31 | 0001818331-24-000008 |
| 2024-02-20 | 16:28 ET | [8-K](/filings/0001818331-24-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818331-24-000006 |
| 2024-01-08 | 08:58 ET | [8-K](/filings/0001818331-24-000003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818331-24-000003 |
| 2023-11-17 | 16:15 ET | [SC 13D/A](/filings/0001213900-23-088332.md) | Ownership report, active investor, amended | 0001213900-23-088332 |
| 2023-11-03 | 16:06 ET | [10-Q](/filings/0001818331-23-000068.md) | Quarterly report, period 2023-09-30 | 0001818331-23-000068 |
| 2023-10-30 | 16:33 ET | [8-K](/filings/0001818331-23-000066.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001818331-23-000066 |

Page 1 of 3. [Older](/companies/wgs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.